ONCOLOGY

BRAF Inhibitors

Nov 1, 2025 by in ONCOLOGY Comments Off on BRAF Inhibitors

BRAF Inhibitors Jordan Talia Christine M. Cornejo Jesse Hirner BRAF is an oncogene encoding the BRAF protein, a component of the MAPK signaling pathway, that regulates cell proliferation, differentiation, survival,…

read more

Epidermal Growth Factor Receptor (EGFR) Inhibitors

Nov 1, 2025 by in ONCOLOGY Comments Off on Epidermal Growth Factor Receptor (EGFR) Inhibitors

Epidermal Growth Factor Receptor (EGFR) Inhibitors Timothy M. Dang Daniela Kroshinsky The human epidermal growth factor receptor (HER) family of proteins is normally involved in cell growth and survival.1 HER1,…

read more

Bleomycin

Nov 1, 2025 by in ONCOLOGY Comments Off on Bleomycin

Bleomycin Jasmine Rana Bernice Y. Kwong A fermentation product of Streptococcus verticillus, bleomycin exerts a cytotoxic effect on replicating cells by inducing DNA double strand breaks. Bleomycin is administered systemically…

read more

Microtubule Inhibitors

Nov 1, 2025 by in ONCOLOGY Comments Off on Microtubule Inhibitors

Microtubule Inhibitors Timothy M. Dang Daniela Kroshinsky Microtubule inhibitors are comprised of largely two classes of chemotherapy—taxanes and vinca alkaloids. Taxanes are cytotoxic drugs that promote the polymerization of tubulin…

read more

Anthracyclines

Nov 1, 2025 by in ONCOLOGY Comments Off on Anthracyclines

Anthracyclines Emma H. Weiss Caroline A. Nelson Jonathan S. Leventhal Anthracycline antibiotics are derived from Streptomyces species and are a commonly used cytotoxic treatment for both solid and hematologic malignancies…

read more

Antimetabolites

Nov 1, 2025 by in ONCOLOGY Comments Off on Antimetabolites

Antimetabolites Sheila Shaigany Paul I. Schneiderman Antimetabolites represent a broad class of chemotherapy agents that halt tumor growth by disrupting cellular division in the S phase of the cell cycle….

read more

Topoisomerase Inhibitors

Nov 1, 2025 by in ONCOLOGY Comments Off on Topoisomerase Inhibitors

Topoisomerase Inhibitors Abdulhadi Jfri Christopher Iriarte Victor Huang Topoisomerases are enzymes involved in DNA structure, specifically in breaking and rejoining the phosphodiester backbone of double stranded DNA.1 Topoisomerase I inhibitors…

read more

Alkylating Agents

Nov 1, 2025 by in ONCOLOGY Comments Off on Alkylating Agents

Alkylating Agents Sheila Shaigany Alkylating agents are highly reactive cytotoxic agents that damage DNA by covalently attaching an alkyl group to guanine molecules present in DNA. This leads directly to…

read more

Severe Cutaneous Adverse Reactions

Nov 1, 2025 by in ONCOLOGY Comments Off on Severe Cutaneous Adverse Reactions

Severe Cutaneous Adverse Reactions Elisa M. Schunkert Andrew C. Walls Severe cutaneous adverse reactions (SCARs) to drugs include several potentially lifethreatening conditions, such as: SJS/TEN (Stevens-Johnson syndrome/toxic epidermal necrolysis) SJS/TEN-like…

read more

Inflamed Actinic Keratoses

Nov 1, 2025 by in ONCOLOGY Comments Off on Inflamed Actinic Keratoses

Inflamed Actinic Keratoses Emma H. Weiss Caroline A. Nelson Jonathan S. Leventhal Inflammation of clinical and subclinical actinic keratoses is commonly seen with systemic administration of antimetabolites, such as 5-fluorouracil,…

read more
Get Clinical Tree app for offline access